Association study of personality factors and the Asn40Asp polymorphism at the μ-opioid receptor gene (OPRM1)

Psychiatric Genetics

Volumn 14, Issue 2, 2004, Pages 89-92

  Hernandez Avila, Carlos A ^a   Covault, Jonathan ^a   Gelernter, Joel ^b,c   Kranzler, Henry R ^a,d  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NONE   (United States)

Author keywords

A118G; Asn40Asp; NEO FFI; Opioid receptor; Personality

Indexed keywords

ASPARAGINE; ASPARTIC ACID; MU OPIATE RECEPTOR;

ADULT; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DEMOGRAPHY; DNA POLYMORPHISM; EXTRAVERSION; FEMALE; GENOTYPE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; NEUROSIS; PERSONALITY DISORDER; PRIORITY JOURNAL; SUBSTANCE ABUSE;

EID: 2942633507     PISSN: 09558829     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ypg.0000107931.32051.c7     Document Type: Article

References (26)

1. Bergen AW, Kokoszka J, Peterson R, Long JC, Virkkunen M, Linnoila M, et al. (1997). Muopioid receptor gene variants: lack of association with alcohol dependence. Mol Psychiatry 2:490-494.
2. Blouin AG, Perez EL, Blouin JH (1988). Computerized administration of the diagnostic interview schedule. Psychiatry Res 23:335-344.
3. Bond C, LaForge KS, Tian M, Melia D, Zhang S, Borg L, et al. (1998). Single-nucleotide polymorphism in the human muopioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction. Proc Natl Acad Sci USA 95:9608-9613.
4. Costa PT, Jr McCrae RR (1997). Stability and change in personality assessment: the revised NEO Personality Inventory in the year 2000. J Pers Assess 68:86-94.
5. Crabbe JC, Allen RG, Gaudette ND, Young ER, Kosobud A, Stack J (1981). Strain differences in pituitary beta-endorphin and ACTH content in inbred mice. Brain Res 219:219-223.
6. Cubells JF, Kobayashi K, Nagatsu T, Kidd KK, Kidd JR, Calafell F, et al. (1997). Population genetics of a functional variant of the dopamine beta-hydroxylase gene (DBH). Am J Med Genet 74:374-379.
7. de Waele JP, Papachristou DN, Gianoulakis C (1992). The alcohol-preferring C57BL/6 mice present an enhanced sensitivity of the hypothalamic beta-endorphin system to ethanol than the alcohol-avoiding DBA/2 mice. J Pharmacol Exp Ther 261:788-794.
8. Eskelson CD, Hameroff SR, Kanel JS (1980). Ethanol increases serum beta-endorphin levels in rats. Anesth Analg 59:537-538.
9. Gelernter J, Kranzler H, Cubells J (1999). Genetics of two mu opioid receptor gene (OPRM1) exon I polymorphisms: population studies, and allele frequencies in alcohol- and drug-dependent subjects. Mol Psychiatry 4:476-483.
10. Gianoulakis C, Gupta A (1986). Inbred strains of mice with variable sensitivity to ethanol exhibit differences in the content and processing of beta-endorphin. Life Sci 39:2315-2325.
11. Gianoulakis C, de Waele JP, Kiianmaa K (1992). Differences in the brain and pituitary beta-endorphin system between the alcohol-preferring AA and alcohol-avoiding ANA rats. Alcohol Clin Exp Res 16:453-459.
12. Gianoulakis C, Krishnan B, Thavundayil J (1996). Enhanced sensitivity of pituitary beta-endorphin to ethanol in subjects at high risk of alcoholism. Arch Gen Psychiatry 53:250-257.
13. Goldberg LR (1993). The structure of phenotypic personality traits. Am Psychol 48:26-34.
14. Hasin DS, Nunes EV (1998). Comorbidity of alcohol, drug, and psychiatric disorders: epidemiology. In: Kranzler HR, Rounsaville BJ (editors): Dual Diagnosis and Treatment. New York: Marcel Dekker; pp. 1-30.
15. Heim C, Newport DJ, Bonsall R, Miller AH, Nemeroff CB (2001). Altered pituitary-adrenal axis responses to provocative challenge tests in adult survivors of childhood abuse. Am J Psychiatry 158:575-581.
16. Hernandez-Avila CA, Wand G, Gelernter J, Kranzler HR (2003). Association between the cortisol response to opioid blockade and alleles of the Asn40Asp polymorphism at the μ opioid receptor locus (OPRM1). Am J Med Genet 118:60-65.
17. Jorm AF, Prior M, Sanson A, Smart D, Zhang Y, Tan S, et al. (2002). Lack of association of a single-nucleotide polymorphism of the mu-opioid receptor gene with anxiety-related traits: results from a cross-sectional study of adults and a longitudinal study of children. Am J Med Genet 114: 659-664.
18. Livak KJ, Marmaro J, Todd JA (1995). Towards fully automated genome-wide polymorphism screening. Nat Genet 9:341-342.
19. Luo X, Kranzler HR, Zhao H, Gelernter J (2003). Haplotypes at the OPRM1 locus are associated with susceptibility to substance dependence in European-Americans. Am J Med Genet 120:97-108.
20. Martin del Campo AF, Dowson JH, Herbert J, Paykel ES (2000). Diurnal variations in endocrine and psychological responses to 02 mg/kg naloxone administration in patients with major depressive disorder and matched controls. J Affect Disord 57:37-47.
21. Mathieu-Kia AM, Fan LQ, Kreek MJ, Simon EJ, Hiller JM (2001). Mu-, delta- and kappa-opioid receptor populations are differentially altered in distinct areas of postmortem brains of Alzheimer's disease patients. Brain Res 893:121-134.
22. McCrae RR, Costa Jr PT (1997). Personality trait structure as a human universal. Am Psychol 52:509-516.
23. Spitzer RL, Williams JBW, Gibbon M, First MB (1992). The Structured Clinical Interview for DSM-III-R (SCID), I: history, rationale and description. Arch Gen Psychiatry 49:624-629.
24. Tariot PN, Upadhyaya A, Sunderland T, Cox C, Cohen RM, Murphy DL, et al. (1999). Physiologic and neuroendocrine responses to intravenous naloxone in subjects with Alzheimer's disease and age-matched controls. Biol Psychiatry 46:412-419.
25. Verheul R, van den Brink W, Ball S (1998). Substance abuse and personality disorders. In: Kranzler HR, Rounsaville BJ (editors): Dual Diagnosis and Treatment. New York: Marcel Dekker; pp. 317-363.
26. Wand GS, McCaul M, Yang X, Reynolds J, Gotjen D, Lee S, et al. (2002). The mu-opioid receptor gene polymorphism (A118G) alters HPA axis activation induced by opioid receptor blockade. Neuropsychopharmacology 26: 106-114.